Vimarsana
Biggest News Aggregation in the World

Page 13 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Pharma Today - Breaking & Trending Today

Small Pharma Inc. (OTCMKTS:DMTTF) Sees Significant Decline in Short Interest - Vimarsana News

Small Pharma Inc. (OTCMKTS:DMTTF) Sees Significant Decline in Short Interest

Small Pharma Inc. (OTCMKTS:DMTTF – Get Rating) saw a significant drop in short interest in April. As of April 30th, there was short interest totalling 130,700 shares, a drop of 22.5% from the April 15th total of 168,700 shares. Based on an average daily volume of 122,300 shares, the days-to-cover ratio is currently 1.1 days. […]

Small Pharma (CVE:DMT) Reaches New 12-Month Low at $0.07 - Vimarsana News

Small Pharma (CVE:DMT) Reaches New 12-Month Low at $0.07

Small Pharma Inc. (CVE:DMT – Get Rating)’s share price reached a new 52-week low on Monday . The stock traded as low as C$0.07 and last traded at C$0.06, with a volume of 6004 shares trading hands. The stock had previously closed at C$0.06. Analysts Set New Price Targets Separately, Roth Capital reissued a “buy” […]

Small Pharma (CVE:DMT) Reaches New 52-Week Low at $0.07 - Vimarsana News

Small Pharma (CVE:DMT) Reaches New 52-Week Low at $0.07

Small Pharma Inc. (CVE:DMT – Get Rating) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 24235 shares. The stock had previously closed at C$0.07. Analyst Upgrades and Downgrades Separately, Roth Capital reiterated a “buy” rating on […]

Small Pharma (CVE:DMT) Reaches New 52-Week Low at $0.07 - Vimarsana News

Small Pharma (CVE:DMT) Reaches New 52-Week Low at $0.07

Small Pharma Inc. (CVE:DMT – Get Rating)’s share price hit a new 52-week low on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 24235 shares traded. The stock had previously closed at C$0.07. Wall Street Analysts Forecast Growth Separately, Roth Capital restated a “buy” rating […]

Source: wkrb13.com
Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology - Vimarsana News

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

Chief Medical and Scientific Officer, Dr. Carol Routledge, will deliver a poster presentation on data from the Company’s SPL026 Phase IIa clinical trial in patients with Major Depressive... | May 3, 2023